137 related articles for article (PubMed ID: 1106927)
1. Randomized trial of transfer factor treatment of human warts.
Stevens DA; Ferrington RA; Merigan TC; Marinkovich VA
Clin Exp Immunol; 1975 Sep; 21(3):520-4. PubMed ID: 1106927
[TBL] [Abstract][Full Text] [Related]
2. Cellular immunity in patients with the Wiskott-Aldrich syndrome before and after administration of transfer factor: a follow-up study.
Schut BJ; Dooren LJ; Uittenbogaart CH; Schellekens PT; Eijsvoogel VP
Immunology; 1979 Jan; 36(1):1-12. PubMed ID: 369991
[TBL] [Abstract][Full Text] [Related]
3. [Successful treatment of Wiscott-Aldrich syndrome with transfer factor].
Endre L; Nékám K; Osváth P; Nagy M; Károly U; Uhl K
Orv Hetil; 1979 Sep; 120(39):2361-6. PubMed ID: 392396
[No Abstract] [Full Text] [Related]
4. Nephropathy in the Wiskott-Aldrich syndrome.
Spitler LE; Wray BB; Mogerman S; Miller JJ; O'Reilly RJ; Lagios M
Pediatrics; 1980 Sep; 66(3):391-8. PubMed ID: 7422429
[TBL] [Abstract][Full Text] [Related]
5. The Wiskott-Aldrich syndrome. Results of transfer factor therapy.
Spitler LE; Levin AS; Stites DP; Fudenberg HH; Pirofsky B; August CS; Stiehm ER; Hitzig WH; Gatti RA
J Clin Invest; 1972 Dec; 51(12):3216-24. PubMed ID: 4640955
[TBL] [Abstract][Full Text] [Related]
6. Topical 5-fluorouracil has no additional benefit in treating common warts with cryotherapy: a single-centre, double-blind, randomized, placebo-controlled trial.
Luk NM; Tang WY; Tang NL; Chan SW; Wong JK; Hon KL; Lo KK
Clin Exp Dermatol; 2006 May; 31(3):394-7. PubMed ID: 16681586
[TBL] [Abstract][Full Text] [Related]
7. Abnormal immune responses in the ocular presentation of Wiskott-Aldrich syndrome.
Guss RB; McCulley JP
Ann Ophthalmol; 1982 Nov; 14(11):1058-60. PubMed ID: 7181336
[TBL] [Abstract][Full Text] [Related]
8. Transfer factor therapy: evidence for nonspecificity.
Ballow M; Dupont B; Hansen JA; Good RA
Birth Defects Orig Artic Ser; 1975; 11(1):457-61. PubMed ID: 125119
[TBL] [Abstract][Full Text] [Related]
9. [Preliminary experience with the treatment of a case of Wiskott-Aldrich syndrome with transfer factor].
Balsamo V; Brai M; Mogavero S; Tolone G; La Grutta A
Minerva Pediatr; 1977 Mar; 29(10):651-5. PubMed ID: 875932
[No Abstract] [Full Text] [Related]
10. The oldest survivor with Wiskott-Aldrich syndrome.
Pritikin RI; Fudenberg HH
Metab Pediatr Ophthalmol; 1980; 4(3):169-71. PubMed ID: 7453283
[No Abstract] [Full Text] [Related]
11. [Discrepancy between the clinical and immunologic picture of in vitro diagnosis during transfer factor therapy in a patient with Wiscott-Aldrich syndrome].
Schütt C; Eggers G; Schröder I; Kruse H; Schulz M; Blau HJ
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):677-84. PubMed ID: 6198251
[TBL] [Abstract][Full Text] [Related]
12. Transfer factor in the treatment of chronic mucocutaneous candidiasis: a controlled study.
Mobacken H; Hanson LA; Lindholm L; Ljunggren C
Acta Derm Venereol; 1980; 60(1):51-5. PubMed ID: 6153834
[TBL] [Abstract][Full Text] [Related]
13. Duct tape for the treatment of common warts in adults: a double-blind randomized controlled trial.
Wenner R; Askari SK; Cham PM; Kedrowski DA; Liu A; Warshaw EM
Arch Dermatol; 2007 Mar; 143(3):309-13. PubMed ID: 17372095
[TBL] [Abstract][Full Text] [Related]
14. [Transfer factor and thymosin in the treatment of Wiskott-Aldrich syndrome].
Franchi F; Segni G; Stabile A; Ammirati P; Aiuti F
Minerva Pediatr; 1978 Apr; 30(8):609-13. PubMed ID: 661768
[No Abstract] [Full Text] [Related]
15. ["Transfer factor". Experimental findings and prospects for its clinical use].
Medunitsyn NV
Patol Fiziol Eksp Ter; 1977; (1):75-80. PubMed ID: 325478
[No Abstract] [Full Text] [Related]
16. [Transfer factor (its use in immunotherapy of neoplasms and other diseases)].
Zduńczyk A
Wiad Lek; 1980 Jun; 33(11):877-81. PubMed ID: 6999743
[No Abstract] [Full Text] [Related]
17. Transfer factor and hepatitis B: a double blind study.
Ellis-Pegler R; Sutherland DC; Douglas R; Woodfield DG; Wilson JD
Clin Exp Immunol; 1979 May; 36(2):221-6. PubMed ID: 477025
[TBL] [Abstract][Full Text] [Related]
18. Transfer factor II: results of therapy.
Spitler LE; Levin AS; Fudenberg HH
Birth Defects Orig Artic Ser; 1975; 11(1):449-56. PubMed ID: 1096990
[TBL] [Abstract][Full Text] [Related]
19. [Changes in the antibody dependent cytotoxicity under the effect of transfer factor therapy. Preliminary report].
Láng I; Nékám K; Török K; Gergely P
Orv Hetil; 1979 Jun; 120(25):1491-5. PubMed ID: 471469
[No Abstract] [Full Text] [Related]
20. Transfer factor therapy in immunodeficiency.
Griscelli C
Birth Defects Orig Artic Ser; 1975; 11(1):462-4. PubMed ID: 1148388
[No Abstract] [Full Text] [Related]
[Next] [New Search]
